Proton pump inhibitors and risk for recurrent ischemic events or death in outpatients with symptomatic artery disease

This publication has 24 references indexed in Scilit:

• Proton Pump Inhibitors and Risk of 1-Year Mortality and Rehospitalization in Older Patients Discharged From Acute Care Hospitals
  JAMA Internal Medicine, 2013
• Smoking cessation and outcome in stable outpatients with coronary, cerebrovascular, or peripheral artery disease
  European Journal of Preventive Cardiology, 2011
• Alcohol consumption and outcome in stable outpatients with peripheral artery disease
  Journal of Vascular Surgery, 2011
• Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study
  BMJ, 2011
• Concomitant Use of Proton Pump Inhibitors and Clopidogrel in Patients With Coronary, Cerebrovascular, or Peripheral Artery Disease in the Factores de Riesgo y ENfermedad Arterial (FRENA) Registry
  Journal of Cardiovascular Pharmacology, 2011
• Glucose control and outcome in patients with stable diabetes and previous coronary, cerebrovascular or peripheral artery disease. Findings from the FRENA Registry
  Diabetic Medicine, 2010
• Proton-Pump Inhibitors Are Associated With Increased Cardiovascular Risk Independent of Clopidogrel Use
  Annals of Internal Medicine, 2010
• Proton Pump Inhibitors and Clopidogrel
  Circulation, 2009
• Body mass index and outcome in patients with coronary, cerebrovascular, or peripheral artery disease: findings from the FRENA registry
  European Journal of Preventive Cardiology, 2009
• A population-based study of the drug interaction between proton pump inhibitors and clopidogrel
  Canadian Medical Association Journal, 2009